Ajanta Pharma Ltd Half Yearly Results

Gross Sales

2,331.56

2,159.23

2,049.48

1,853.61

1,889.03

Excise Duty

0

0

0

0

0

Net Sales

2,331.56

2,159.23

2,049.48

1,853.61

1,889.03

Other Operating Income

0

0

0

0

0

Other Income

45.95

41.51

43.09

25.53

73.11

Total Income

2,377.51

2,200.74

2,092.57

1,879.14

1,962.14

Total Expenditure

1,690.04

1,559.26

1,477.51

1,488.46

1,470.93

PBIDT

687.47

641.48

615.06

390.68

491.21

Interest

6.75

4.02

3.19

3.97

1.87

PBDT

680.72

637.46

611.87

386.71

489.34

Depreciation

68.36

68.51

66.89

66.32

64.48

Minority Interest Before NP

0

0

0

0

0

Tax

155.49

164.42

157.64

95.36

101.88

Deferred Tax

-5.38

-8.22

-16.08

-31.73

-8.24

Reported Profit After Tax

462.25

412.75

403.42

256.76

331.22

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

462.25

412.75

403.42

256.76

331.22

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

462.25

412.75

403.42

256.76

331.22

EPS (Unit Curr.)

36.88

32.67

32.04

20.32

25.85

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

1,400

0

0

0

350

Equity

25.07

25.27

25.27

25.27

25.71

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

29.48

29.7

30.01

21.07

26

PBDTM(%)

-

-

-

-

-

PATM(%)

19.82

19.11

19.68

13.85

17.53